Haemostasis tests ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 113 | Muscular dystrophy | 1 |
113. Muscular dystrophy
Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03424460 (ClinicalTrials.gov) | June 11, 2018 | 7/12/2017 | Venous Thromboembolism in Myotonic Dystrophy Type 1 | Venous Thromboembolism in Myotonic Dystrophy Type 1 | Myotonic Dystrophy 1 | Biological: Haemostasis tests;Biological: Monocytes and megacaryocytes culture and RNA extraction;Genetic: RNA extraction | Assistance Publique - Hôpitaux de Paris | AFM-Téléthon (Funding);Recherche Clinique Paris Descartes Necker Cochin Sainte Anne | Recruiting | 18 Years | N/A | All | 130 | N/A | France |